Do you have: a logo for your business? a colour or graphic used for your packaging, website or brochures? unique technology that you have developed to sell or use in your business? a unique method or plan for how you do business? a recipe you use to make material you work with? If the answer …
>> Read more
If you own or manage a business you may be surprised by how much valuable intellectual property (IP) you have. Protecting your IP is critical when establishing your product or service in the market. It provides a competitive advantage for your business and can be the key difference between success and failure. Failure to secure …
>> Read more
Implementation of the single trans-Tasman patent application (Australia and New Zealand) appears to have been terminated through the surprise recommendations of the New Zealand government’s Commerce Committee issued on 13 July 2016. New Zealand government’s Commerce Committee published an updated Patents (Trans-Tasman Patent Attorneys and Other Matters) Amendment Bill on 13 July 2016 which recommended …
>> Read more
Omnibus claims are now effectively prohibited following the Raising the Bar amendments, however a great many patents including such claims have been granted. The Full Federal Court decision,GlaxoSmithKline Australia Pty Ltd v Reckitt Benckiser Healthcare (UK) Ltd [2016] FCAFC 90, provides some welcome guidance on how such claims should be construed. At trial, it had …
>> Read more
We are delighted to announce the appointment of our new Managing Partner, Ross McFarlane. Ross will take up his new role on 1 July 2016. Ross has been a Partner since 2006, and was elected to the POF Group Board in 2011. He is a member of the Electronics, Physics and IT practice group, and …
>> Read more
We are pleased to announce the appointment of three new Senior Associates and two new Associates, effective from 1 July 2016. Our new Senior Associates are: Magda Bramante BSc LLB LLM Magda has a wide range of experience in all aspects of IP including patent, design, trade mark, copyright and trade practices issues. Magda is also …
>> Read more
The rise and fall of Theranos has seen the unravelling of this US based health-technology start-up, with the once heralded company now under criminal investigation and facing a class action. We are proud to host BioMelbourne’s BioBriefing session: “Health-Tech and Hype: Lessons from Theranos” to be held on 5 July 2016. At this event, a …
>> Read more
Following a referendum vote on 23 June 2016, the British electorate has decided to leave the European Union (EU). However, it is likely to be at least 2 years before legislation is enacted to enable the United Kingdom (UK) to exit the EU. During that time, EU legislation remains in effect. Key messages relating to …
>> Read more
We are pleased to announce that POF partner, Russell Waters, has been recognised as an Expert Guide in Euromoney’s Trade mark Expert Guides 2016. Partners Greg Chambers and Ross McFarlane have also been recognised for their expertise in the Patents Experts Guides. For 20 years, the Expert Guides have consolidated a database of the growing …
>> Read more
In May 2016, The High Court of Australia dismissed an application for special leave to appeal the RPL Central decision1 of the Full Court of the Federal Court of Australia. The Full Federal Court found that RPL Central’s invention was not patentable as it was simply a scheme or idea implemented on a generic computer, …
>> Read more
